OXFORD BIOMEDICA

SME

OXFORD BIOMEDICA

Description

Oxford Biomedica develops LentiVector platform and a gene and cell therapy designed for oncology, CNS disorders and liver diseases.

OXFORD BIOMEDICA

Address

TRANSPORT WAY OXFORDOX4 6LT UNITED KINGDOM
United Kingdom

Contact

enquiries@oxb.com

Description

Oxford Biomedica develops LentiVector platform and a gene and cell therapy designed for oncology, CNS disorders and liver diseases.

Matchmaking

Connect with OXFORD BIOMEDICA

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL